The acellular dermal matrices market size has grown strongly in recent years. It will grow from $1.61 billion in 2025 to $1.77 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to increasing volume of reconstructive surgeries, rising incidence of chronic wounds, growing use of biomaterials in surgery, advancements in tissue processing techniques, expanding cosmetic and plastic surgery demand.
The acellular dermal matrices market size is expected to see strong growth in the next few years. It will grow to $2.55 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to increasing demand for regenerative medicine solutions, rising adoption of advanced wound care products, expansion of minimally invasive surgical procedures, growing focus on faster healing outcomes, increasing clinical acceptance of biologic implants. Major trends in the forecast period include increasing adoption of adms in reconstructive surgeries, rising use of biologic scaffolds in wound care, growing preference for ready-to-use dermal matrices, expansion of adm applications in orthopedic procedures, enhanced focus on biocompatibility and healing outcomes.
The rising number of chronic wounds is expected to significantly drive the growth of the acellular dermal matrices market in the coming years. Chronic wounds are injuries or sores that either heal very slowly or do not heal at all, often recurring and requiring specialized treatment. The growing prevalence of these wounds is closely linked to the increasing number of individuals with diabetes. Diabetes can impair blood circulation and damage nerves, making it more difficult for the body to heal even minor cuts, which can then develop into serious and persistent wounds. Acellular dermal matrices assist in managing chronic wounds by serving as a supportive scaffold that promotes natural tissue regeneration and speeds up the healing process. For example, in July 2023, OSF HealthCare, a nonprofit healthcare organization based in the U.S., reported that 6.7 million people in the country are currently affected by chronic wounds, with this number projected to grow by 2% annually over the next ten years. Therefore, the increasing prevalence of chronic wounds is fueling the expansion of the acellular dermal matrices market.
Leading companies in the acellular dermal matrices market are focusing on product innovation by developing dual-sided grafts to improve surgical versatility and ease of use. Dual-sided acellular dermal matrices are advanced grafts designed with two functional surfaces, allowing for more flexible implantation and streamlined handling during surgery. For instance, in May 2023, AlloSource, a U.S.-based nonprofit organization that supplies allografts derived from human tissue for medical procedures, introduced AlloMend Duo Acellular Dermal Matrix (ADM). This product is designed specifically for soft tissue reconstruction, offering surgeons a dependable option for restoring and reinforcing soft tissue defects. The deep reticular dermal allograft is engineered to integrate well with surrounding tissues, providing a scaffold that encourages cellular repopulation and the regeneration of native tissue.
In March 2023, Aziyo Biologics, a U.S.-based regenerative medicine company, entered into a partnership with Sientra Inc. to broaden access to biologic solutions for soft tissue reconstruction. This collaboration focuses on increasing the availability of SimpliDerm, an acellular dermal matrix, to support procedures such as breast reconstruction. The initiative is aimed at improving access to biologic products for women undergoing reconstructive surgery. Sientra Inc. is a U.S.-based medical aesthetics company that produces silicone breast implants and other products for cosmetic and reconstructive breast procedures.
Major companies operating in the acellular dermal matrices market are Stryker Corporation, Smith & Nephew plc, ConvaTec Group plc, Integra LifeSciences Corporation, Gunze Limited, MTF Biologics, Organogenesis Inc., RTI Surgical Holdings Inc., LifeNet Health, HANS BIOMED, PolyNovo Limited, Cook Biotech Incorporated, Tissue Regenix Group plc, CG Bio Inc., Meccellis Biotech, Aziyo Biologics Inc., MiMedx Group Inc., Axogen Inc., AlloSource, Kerecis Ltd.
North America was the largest region in the acellular dermal matrices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acellular dermal matrices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the acellular dermal matrices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the acellular dermal matrices market by increasing costs of imported biologic raw materials, processing equipment, sterilization systems, and cold-chain logistics components. Hospitals and specialty surgical centers in North America and Europe are most affected due to reliance on imported ADM products, while Asia-Pacific faces pricing pressure on export-oriented production. These tariffs are raising procedure costs and impacting procurement budgets. However, they are also encouraging local tissue processing facilities, regional manufacturing expansion, and investment in alternative biologic and composite dermal matrix technologies.
The acellular dermal matrices market research report is one of a series of new reports that provides acellular dermal matrices market statistics, including acellular dermal matrices industry global market size, regional shares, competitors with a acellular dermal matrices market share, detailed acellular dermal matrices market segments, market trends and opportunities, and any further data you may need to thrive in the acellular dermal matrices industry. This acellular dermal matrices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Acellular dermal matrices (ADMs) are natural materials derived from skin tissue that undergo processing to remove all cellular components. These materials are utilized in surgical procedures to repair or replace damaged tissues. Serving as a scaffold, ADMs promote the growth and healing of new tissue. They are commonly used in procedures such as breast reconstruction and wound healing to support the regeneration of skin and soft tissues.
The primary types of acellular dermal matrices include human acellular dermal matrices, porcine acellular dermal matrices, and other source-derived acellular dermal matrices. Human acellular dermal matrices (HADMs) are biomaterials obtained from donated human skin, with all cellular components removed, leaving behind a collagen-rich structure that aids in tissue regeneration during reconstructive and surgical procedures. These products are distributed through various channels, such as direct sales, online platforms, and distributor networks. They are employed in a range of applications, including breast reconstruction, dental surgery, orthopedic surgery, wound care, and other medical procedures, with end users including hospitals, ambulatory surgical centers, specialty clinics, and research laboratories.
The acellular dermal matrices market includes sales of xenogeneic acellular dermal matrices, collagen-based acellular dermal matrices, bi-layered acellular dermal matrices, and dermal substitute products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The acellular dermal matrices market size is expected to see strong growth in the next few years. It will grow to $2.55 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to increasing demand for regenerative medicine solutions, rising adoption of advanced wound care products, expansion of minimally invasive surgical procedures, growing focus on faster healing outcomes, increasing clinical acceptance of biologic implants. Major trends in the forecast period include increasing adoption of adms in reconstructive surgeries, rising use of biologic scaffolds in wound care, growing preference for ready-to-use dermal matrices, expansion of adm applications in orthopedic procedures, enhanced focus on biocompatibility and healing outcomes.
The rising number of chronic wounds is expected to significantly drive the growth of the acellular dermal matrices market in the coming years. Chronic wounds are injuries or sores that either heal very slowly or do not heal at all, often recurring and requiring specialized treatment. The growing prevalence of these wounds is closely linked to the increasing number of individuals with diabetes. Diabetes can impair blood circulation and damage nerves, making it more difficult for the body to heal even minor cuts, which can then develop into serious and persistent wounds. Acellular dermal matrices assist in managing chronic wounds by serving as a supportive scaffold that promotes natural tissue regeneration and speeds up the healing process. For example, in July 2023, OSF HealthCare, a nonprofit healthcare organization based in the U.S., reported that 6.7 million people in the country are currently affected by chronic wounds, with this number projected to grow by 2% annually over the next ten years. Therefore, the increasing prevalence of chronic wounds is fueling the expansion of the acellular dermal matrices market.
Leading companies in the acellular dermal matrices market are focusing on product innovation by developing dual-sided grafts to improve surgical versatility and ease of use. Dual-sided acellular dermal matrices are advanced grafts designed with two functional surfaces, allowing for more flexible implantation and streamlined handling during surgery. For instance, in May 2023, AlloSource, a U.S.-based nonprofit organization that supplies allografts derived from human tissue for medical procedures, introduced AlloMend Duo Acellular Dermal Matrix (ADM). This product is designed specifically for soft tissue reconstruction, offering surgeons a dependable option for restoring and reinforcing soft tissue defects. The deep reticular dermal allograft is engineered to integrate well with surrounding tissues, providing a scaffold that encourages cellular repopulation and the regeneration of native tissue.
In March 2023, Aziyo Biologics, a U.S.-based regenerative medicine company, entered into a partnership with Sientra Inc. to broaden access to biologic solutions for soft tissue reconstruction. This collaboration focuses on increasing the availability of SimpliDerm, an acellular dermal matrix, to support procedures such as breast reconstruction. The initiative is aimed at improving access to biologic products for women undergoing reconstructive surgery. Sientra Inc. is a U.S.-based medical aesthetics company that produces silicone breast implants and other products for cosmetic and reconstructive breast procedures.
Major companies operating in the acellular dermal matrices market are Stryker Corporation, Smith & Nephew plc, ConvaTec Group plc, Integra LifeSciences Corporation, Gunze Limited, MTF Biologics, Organogenesis Inc., RTI Surgical Holdings Inc., LifeNet Health, HANS BIOMED, PolyNovo Limited, Cook Biotech Incorporated, Tissue Regenix Group plc, CG Bio Inc., Meccellis Biotech, Aziyo Biologics Inc., MiMedx Group Inc., Axogen Inc., AlloSource, Kerecis Ltd.
North America was the largest region in the acellular dermal matrices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acellular dermal matrices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the acellular dermal matrices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the acellular dermal matrices market by increasing costs of imported biologic raw materials, processing equipment, sterilization systems, and cold-chain logistics components. Hospitals and specialty surgical centers in North America and Europe are most affected due to reliance on imported ADM products, while Asia-Pacific faces pricing pressure on export-oriented production. These tariffs are raising procedure costs and impacting procurement budgets. However, they are also encouraging local tissue processing facilities, regional manufacturing expansion, and investment in alternative biologic and composite dermal matrix technologies.
The acellular dermal matrices market research report is one of a series of new reports that provides acellular dermal matrices market statistics, including acellular dermal matrices industry global market size, regional shares, competitors with a acellular dermal matrices market share, detailed acellular dermal matrices market segments, market trends and opportunities, and any further data you may need to thrive in the acellular dermal matrices industry. This acellular dermal matrices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Acellular dermal matrices (ADMs) are natural materials derived from skin tissue that undergo processing to remove all cellular components. These materials are utilized in surgical procedures to repair or replace damaged tissues. Serving as a scaffold, ADMs promote the growth and healing of new tissue. They are commonly used in procedures such as breast reconstruction and wound healing to support the regeneration of skin and soft tissues.
The primary types of acellular dermal matrices include human acellular dermal matrices, porcine acellular dermal matrices, and other source-derived acellular dermal matrices. Human acellular dermal matrices (HADMs) are biomaterials obtained from donated human skin, with all cellular components removed, leaving behind a collagen-rich structure that aids in tissue regeneration during reconstructive and surgical procedures. These products are distributed through various channels, such as direct sales, online platforms, and distributor networks. They are employed in a range of applications, including breast reconstruction, dental surgery, orthopedic surgery, wound care, and other medical procedures, with end users including hospitals, ambulatory surgical centers, specialty clinics, and research laboratories.
The acellular dermal matrices market includes sales of xenogeneic acellular dermal matrices, collagen-based acellular dermal matrices, bi-layered acellular dermal matrices, and dermal substitute products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Acellular Dermal Matrices Market Characteristics
3. Acellular Dermal Matrices Market Supply Chain Analysis
4. Global Acellular Dermal Matrices Market Trends and Strategies
5. Acellular Dermal Matrices Market Analysis of End Use Industries
7. Global Acellular Dermal Matrices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Acellular Dermal Matrices Total Addressable Market (TAM) Analysis for the Market
9. Acellular Dermal Matrices Market Segmentation
10. Acellular Dermal Matrices Market Regional and Country Analysis
11. Asia-Pacific Acellular Dermal Matrices Market
12. China Acellular Dermal Matrices Market
13. India Acellular Dermal Matrices Market
14. Japan Acellular Dermal Matrices Market
15. Australia Acellular Dermal Matrices Market
16. Indonesia Acellular Dermal Matrices Market
17. South Korea Acellular Dermal Matrices Market
18. Taiwan Acellular Dermal Matrices Market
19. South East Asia Acellular Dermal Matrices Market
20. Western Europe Acellular Dermal Matrices Market
21. UK Acellular Dermal Matrices Market
22. Germany Acellular Dermal Matrices Market
23. France Acellular Dermal Matrices Market
24. Italy Acellular Dermal Matrices Market
25. Spain Acellular Dermal Matrices Market
26. Eastern Europe Acellular Dermal Matrices Market
27. Russia Acellular Dermal Matrices Market
28. North America Acellular Dermal Matrices Market
29. USA Acellular Dermal Matrices Market
30. Canada Acellular Dermal Matrices Market
31. South America Acellular Dermal Matrices Market
32. Brazil Acellular Dermal Matrices Market
33. Middle East Acellular Dermal Matrices Market
34. Africa Acellular Dermal Matrices Market
36. Acellular Dermal Matrices Market Competitive Landscape and Company Profiles
37. Acellular Dermal Matrices Market Other Major and Innovative Companies
40. Acellular Dermal Matrices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Acellular Dermal Matrices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses acellular dermal matrices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for acellular dermal matrices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The acellular dermal matrices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Human Acellular Dermal Matrices; Porcine Acellular Dermal Matrices; Other Source Acellular Dermal Matrices2) By Distribution Channel: Direct Sales; Online Sales; Distributor Sales
3) By Application: Breast Reconstruction; Dental Surgery; Orthopedic Surgery; Wound Care; Other Applications
4) By End-User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Research Laboratories
Subsegments:
1) By Human Acellular Dermal Matrices: Cryopreserved Human Acellular Dermal Matrices; Freeze-dried Human Acellular Dermal Matrices; Ready-to-use Human Acellular Dermal Matrices2) By Porcine Acellular Dermal Matrices: Cross-linked Porcine Dermis; Non-cross-linked Porcine Dermis; Gamma-irradiated Porcine Matrices
3) By Other Source Acellular Dermal Matrices: Bovine-derived Dermal Matrices; Fish-derived Dermal Matrices; Synthetic Or acellular Composite Matrices
Companies Mentioned: Stryker Corporation; Smith & Nephew plc; ConvaTec Group plc; Integra LifeSciences Corporation; Gunze Limited; MTF Biologics; Organogenesis Inc.; RTI Surgical Holdings Inc.; LifeNet Health; HANS BIOMED; PolyNovo Limited; Cook Biotech Incorporated; Tissue Regenix Group plc; CG Bio Inc.; Meccellis Biotech; Aziyo Biologics Inc.; MiMedx Group Inc.; Axogen Inc.; AlloSource; Kerecis Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Acellular Dermal Matrices market report include:- Stryker Corporation
- Smith & Nephew plc
- ConvaTec Group plc
- Integra LifeSciences Corporation
- Gunze Limited
- MTF Biologics
- Organogenesis Inc.
- RTI Surgical Holdings Inc.
- LifeNet Health
- HANS BIOMED
- PolyNovo Limited
- Cook Biotech Incorporated
- Tissue Regenix Group plc
- CG Bio Inc.
- Meccellis Biotech
- Aziyo Biologics Inc.
- MiMedx Group Inc.
- Axogen Inc.
- AlloSource
- Kerecis Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.77 Billion |
| Forecasted Market Value ( USD | $ 2.55 Billion |
| Compound Annual Growth Rate | 9.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
